Form 4 for MNPR Monopar Therapeutics
Accepted 2024-06-05 00:00:00 ET · period of report 2024-06-03 · accession 0001437749-24-019370 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-06-05 | 2024-06-03+ | MNPR | Cittadine Andrew | COO | P - Purchase | $0.77 | +24.0K | 117.6K | +26% | +$18.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-03 | P | A | 12,000 | $0.76 | 105,624 | D | — | — | |
| 2 | Common | Common Stock | 2024-06-04 | P | A | 12,000 | $0.78 | 117,624 | D | — | — |